|
Rich,
I am a bit confused. Your subject title says (mets), but the text of your information applies to first line and adjuvant settings. Do you mention mets, because the Phase II/III trials were done with BC patients who had mets?
Maybe you don't know the actual answer to this. But, it all sounds very promising.
Thanks,
Cindi
|